Revolution CTGet uncompromised image quality and clinical capabilities through the convergence of coverage, spatial resolution, temporal resolution and spectral imaging.
Q.ClearDo you know your patient’s response score? Q.Clear delivers quantitative SUV you and your patients can trust.
PET/CTThe true potential of PET/CT is its ability to enable a true discovery.
5. Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Jonathon B. Cohen,1 Madhusmita Behera,1 Carrie A. Thompson,2 and Christopher R. Flowerscorresponding author1 Blood. 2017 Feb 2; 129(5): 561–564.